Photo: economictimes.indiatimes.com
Two Gujarat cos under lens for DEG-laden cough syrup; FDA issues alert
Gujarat's FDA has banned specific cough syrup batches from Rednex Pharmaceuticals and Shape Pharmaceutical due to toxic Diethylene Glycol contamination, raising health concerns.
- The Gujarat FDA issued a public alert prohibiting the sale of batches from Rednex Pharmaceuticals and Shape Pharmaceutical due to Diethylene Glycol (DEG) impurities exceeding permissible limits.
- Rednex Pharmaceuticals and Shape Pharmaceutical's cough syrup formulations were found to contain DEG, a toxic substance that poses serious health risks, particularly in cold medicine.
- The alert follows a similar incident in Madhya Pradesh where DEG-tainted cough syrups caused severe adverse reactions, highlighting the ongoing risks associated with contaminated pharmaceuticals.
- The FDA's action underscores the importance of regulatory oversight in the pharmaceutical industry to prevent the distribution of toxic products in Gujarat and beyond.
Why It Matters
This incident raises significant health concerns for consumers relying on cough medicine, especially given the toxicity of Diethylene Glycol. The actions taken by the Gujarat FDA may lead to increased scrutiny of pharmaceutical manufacturers. Stakeholders in the health sector, including patients and healthcare providers, must remain vigilant about product safety and potential recalls.